Literature DB >> 30810795

MRI features of mucinous adenocarcinoma of the prostate: report of four cases.

Kaori Yamada1, Nana Kozawa2, Hitomi Nagano2, Masato Fujita3, Kei Yamada2.   

Abstract

CASE REPORTS: We report four patients with mucinous adenocarcinoma of the prostate, focusing on their magnetic resonance imaging (MRI) findings. The lesions appeared hyperintense on T2-weighted images (T2WI) in all four patients. In the two patients in whom the tumors were confined to the peripheral zone (PZ), the lesions were isointense to the surrounding normal PZ, making them difficult to identify. In all three patients who underwent diffusion-weighted imaging (b = 1000), the lesions appeared hyperintense but visually there was little or no decrease in the apparent diffusion coefficient (ADC), with ADC values of 1.02, 1.39, and 1.66 × 10-3 mm2/s, respectively. In the three patients who underwent a dynamic contrast-enhanced MR study, early enhancement was evident in two (partial in one), and gradually increasing enhancement in one.
CONCLUSION: In the four cases in this instance, MRI findings of mucinous adenocarcinoma were very different from the appearance of non-mucinous adenocarcinoma. It is suggested that the conventional interpretation method of MRI for prostate cancer is not suitable for mucinous adenocarcinoma. Those who interpret prostate MRI should be aware of this rare and unique subtype of prostate cancer.

Entities:  

Keywords:  MRI; Mucinous adenocarcinoma; PI-RADS; Prostate cancer

Mesh:

Year:  2019        PMID: 30810795     DOI: 10.1007/s00261-019-01956-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  1 in total

1.  Case Report: Prostate Adenocarcinoma With Mucinous Features of Normal-Level Serum PSA, Atypical Imaging, Biopsy-Negative, and Peculiar Urethrocystoscopic Manifestation.

Authors:  Yao Zhang; Hua Shen; Kai Liao; Weili Wu; Jiuming Li; Hongbo Yu; Hongfei Wu; Zengjun Wang
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.